Kevin Balthaser | executive |
Neal Walker | executive |
Joseph Monahan | executive |
Jiale Song | analyst |
Thomas Smith | analyst |
Julian Harrison | analyst |
Alexander Thompson | analyst |
Gavin Clark-Gartner | analyst |
Good day, and thank you for standing by. Welcome to the Aclaris Therapeutics First Quarter 2024 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Kevin Balthaser. Please go ahead.
Thank you.